eFFECTOR Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2021 to Q1 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
eFFECTOR Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2021 to Q1 2024.
  • eFFECTOR Therapeutics, Inc. Current Ratio for the quarter ending March 31, 2024 was 92.5 %, a 26.8% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2024 92.5 -33.8 -26.8% Mar 31, 2024
Q4 2023 86.2 -116 -57.4% Dec 31, 2023
Q3 2023 95.1 -230 -70.7% Sep 30, 2023
Q2 2023 110 -155 -58.5% Jun 30, 2023
Q1 2023 126 -169 -57.2% Mar 31, 2023
Q4 2022 202 -22.4 -9.98% Dec 31, 2022
Q3 2022 325 +178 +121% Sep 30, 2022
Q2 2022 265 Jun 30, 2022
Q1 2022 295 Mar 31, 2022
Q4 2021 225 Dec 31, 2021
Q3 2021 147 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.